NAP1L4

Nucleosome assembly protein 1-like 4 · Q99733 · NAP1L4 on Sugi Atlas →

0 patent compounds predicted against NAP1L4, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to NAP1L4 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients PHASE3UNKNOWN
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
LBH589 Treatment for Refractory Clear Cell Renal Carcinoma PHASE2COMPLETED
An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab PHASE1/PHASE2RECRUITING
Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma PHASE1/PHASE2COMPLETED
Phase 1/ Phase 2 Study to Assess Safety and Efficacy of Orally Administered JBI-802 in Subjects With Myeloproliferative Neoplasms (MPN) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) With Thrombocytosis PHASE1/PHASE2RECRUITING
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome PHASE1COMPLETED
Evaluation of the Safety and the Tolerability of a Combination of Two HIV Inducers in Patients With Undetectable Viral Load PHASE1COMPLETED
Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma PHASE1UNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins nanCOMPLETED
Genetics of Neonatal Encephalopathy and Related Disorders nanRECRUITING
Thermogenic Silencer Regulatory Factors in Humans nanACTIVE_NOT_RECRUITING
Impact of Weight Loss on the Human Sperm Epitranscriptome nanACTIVE_NOT_RECRUITING
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus nanACTIVE_NOT_RECRUITING
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia nanUNKNOWN
Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia nanCOMPLETED
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Efficacy of Cognitive Rehabilitation Using Virtual Reality and Computer-based Cognitive Stimulation on Cognitive Impairment Associated to Movement Disorders nanCOMPLETED
Assessment Of Long Noncoding RNA CCAT1 In Colorectal Cancer Patients nanUNKNOWN
X-chromosome Inactivation, Epigenetics and the Transcriptome nanCOMPLETED
Delineation of Novel Monogenic Disorders in the United Arab Emirates Population nanUNKNOWN
Circulating Non-coding RNAs and Cardiovascular Outcomes in Patients With Dyslipidemia and Atherosclerosis nanUNKNOWN
Quantitative Assessment of the Etiologies of Megalencephaly Associated With a Detectable Tumor Risk nanNOT_YET_RECRUITING
Target of Suv420h1/2 in Hepatocytes nanRECRUITING
Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s) nanCOMPLETED
Genetic Study of Families Affected by Paget's Disease of Bone nanCOMPLETED
Using Mobile Technology to Improve Self-Regulation nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a NAP1L4 binder may also engage these)

ProteinNameSimilarity
Q5U2Z3 1.000 Q5U2Z3 →
Q78ZA7 1.000 Q78ZA7 →
Q2TA40 1.000 Q2TA40 →
Q4U0Y4 0.998 Q4U0Y4 →
Q7ZY81 0.996 Q7ZY81 →
Q9Z2G8 0.995 Q9Z2G8 →
Q7X7C9 0.994 Q7X7C9 →
Q28EB4 0.994 Q28EB4 →
Q70Z17 0.994 Q70Z17 →
O59797 0.993 O59797 →
A6H767 0.993 A6H767 →
Q53WK4 0.993 Q53WK4 →
P28656 0.993 P28656 →
Q94K07 0.992 Q94K07 →
Q9SZI2 0.992 Q9SZI2 →
P53997 0.991 P53997 →
Q70Z19 0.991 Q70Z19 →
Q5R4D4 0.990 Q5R4D4 →
B8AW64 0.990 B8AW64 →
NAP1L1 Nucleosome assembly protein 1-like 1 0.990 landscape →
Q69JW2 0.990 Q69JW2 →
B8B2R4 0.990 B8B2R4 →
B8AEC1 0.990 B8AEC1 →
Q5MGA9 0.989 Q5MGA9 →
A2XU85 0.989 A2XU85 →
Q70Z16 0.988 Q70Z16 →
Q5AAI8 0.985 Q5AAI8 →
A2ZX50 0.985 A2ZX50 →
Q70Z18 0.985 Q70Z18 →
B8B4K9 0.985 B8B4K9 →